YS Biopharma Co. Ltd. engages in discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of YS Biopharma Co Ltd - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. YS Biopharma Co Ltd - Ordinary Shares - Class A market cap is $334.75M.
What is the 52-week high for YS Biopharma Co Ltd - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. YS Biopharma Co Ltd - Ordinary Shares - Class A 52 week high is $18.44 as of September 25, 2025.
What is the 52-week low for YS Biopharma Co Ltd - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. YS Biopharma Co Ltd - Ordinary Shares - Class A 52 week low is $9.20 as of September 25, 2025.
What is YS Biopharma Co Ltd - Ordinary Shares - Class A stock price today?
YS Biopharma Co Ltd - Ordinary Shares - Class A stock price today is $1.48.
What was YS Biopharma Co Ltd - Ordinary Shares - Class A stock price yesterday?
YS Biopharma Co Ltd - Ordinary Shares - Class A stock price yesterday was $1.44.
What is the PE ratio of YS Biopharma Co Ltd - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. YS Biopharma Co Ltd - Ordinary Shares - Class A’s P/E ratio is 19.40.
What is the Price-to-Book ratio of YS Biopharma Co Ltd - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. YS Biopharma Co Ltd - Ordinary Shares - Class A P/B ratio is 1.7146.
What is the 50-day moving average of YS Biopharma Co Ltd - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. YS Biopharma Co Ltd - Ordinary Shares - Class A 50-day moving average is $10.24.
